| NEPTUNE Match Study (NCT04571658) | University of Michigan | 2022-05-02 |
| Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. (NCT05505500) | University of Michigan | 2022-04-18 |
| Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN) (NCT05162066) | BioCryst Pharmaceuticals | 2022-02-18 |
| Obinutuzumab in Primary MN (NCT05050214) | Mario Negri Institute for Pharmacological Research | 2022-02-18 |
| MOR202 for Refractory MN (NCT04893096) | Mario Negri Institute for Pharmacological Research | 2021-10-22 |
| Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy (NCT04652570) | Tenet Medicines | 2021-05-05 |
| A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome (NCT04278729) | University of North Carolina, Chapel Hill | 2021-04-14 |
| Raman Spectroscopy Diagnosis of Kidney Diseases (NCT06760845) | Zunsong Wang | 2021-02-01 |
| Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE) (NCT04733040) | HI-Bio, A Biogen Company | 2021-01-20 |
| Immunopathological Analysis in a French National Cohort of Membranous Nephropathy (NCT04326218) | Centre Hospitalier Universitaire de Nice | 2020-07-04 |
| Belimumab With Rituximab for Primary Membranous Nephropathy (NCT03949855) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-03-06 |
| Autoreactive B Cells in Membranous Nephropathy (NCT04095156) | Mario Negri Institute for Pharmacological Research | 2019-09-25 |
| KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis (NCT03929887) | Seoul National University Hospital | 2019-05-01 |
| Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies (NCT03453619) | Apellis Pharmaceuticals, Inc. | 2018-02-26 |
| Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy (NCT02199145) | Centre Hospitalier Universitaire de Nice | 2015-07-17 |
| Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy (NCT01955187) | Hospital Universitario 12 de Octubre | 2014-01-01 |
| Nephrotic Syndrome Study Network (NCT01209000) | University of Michigan | 2010-04-01 |
| National Registry of Rare Kidney Diseases (NCT06065852) | UK Kidney Association | 2009-11-06 |
| To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN) (NCT00518219) | Nanjing University School of Medicine | 2007-07-01 |
| Rituximab in the Treatment of Idiopathic Membranous Nephropathy (NCT00405340) | Mayo Clinic | 2006-10-01 |
| The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy (NCT00983034) | Istanbul University | 2006-03-01 |
| Rituximab in Membranous Nephropathy (NCT00425217) | Mayo Clinic | 2004-08-01 |